Skip to main content
. 2021 Jul 9;4(7):e2115675. doi: 10.1001/jamanetworkopen.2021.15675

Table 1. Patient Demographic and Clinical Characteristics by Hospital Type From 2007 to 2016.

Variable Patientsa
Community hospital (n = 2 078 051) Academic hospital (n = 979 318) NCI hospital (n = 583 994) Integrated hospital (n = 577 214) Total (N = 4 218 577)
Age, mean (SD), y 65.8 (11.5) 64.2 (11.2) 63.3 (10.9) 65.0 (11.4) 65.0 (11.4)
Sex
Male 865 016 (41.6) 430 780 (44.0) 294 081 (50.4) 241 124 (41.8) 1 831 001 (43.4)
Female 1 213 035 (58.4) 548 538 (56.0) 289 913 (49.6) 336 090 (58.2) 2 387 576 (56.6)
Race
White 1 818 997 (87.5) 774 035 (79.0) 487 788 (83.5) 487 886 (84.5) 3 568 706 (84.6)
Black 186 504 (9.0) 149 189 (15.2) 63 963 (11.0) 66 508 (11.5) 466 164 (11.1)
Asian 43 967 (2.1) 32 357 (3.3) 17 137 (2.9) 10 589 (1.8) 104 050 (2.5)
American Indian 7367 (0.4) 1612 (0.2) 1895 (0.3) 833 (0.1) 11 707 (0.3)
Other 9496 (0.5) 10 720 (1.1) 5195 (0.9) 4458 (0.8) 29 869 (0.7)
Missing 11 720 (0.6) 11 405 (1.2) 8016 (1.4) 6940 (1.2) 38 081 (0.9)
Ethnicity
Non-Hispanic 1 902 354 (91.5) 869 020 (88.7) 543 230 (93.0) 522 444 (90.5) 3 837 048 (91.0)
Hispanic 77 450 (3.7) 59 226 (6.0) 25 360 (4.3) 24 467 (4.2) 186 503 (4.4)
Missing 98 247 (4.7) 51 072 (5.2) 15 404 (2.6) 30 303 (5.2) 195 026 (4.6)
Incomeb
Quartile 1 361 532 (17.4) 180 533 (18.4) 85 470 (14.6) 82 909 (14.4) 710 444 (16.8)
Quartile 2 508 735 (24.5) 183 914 (18.8) 116 274 (19.9) 119 498 (20.7) 928 421 (22.0)
Quartile 3 543 412 (26.2) 232 049 (23.7) 133 417 (22.8) 156 536 (27.1) 1 065 414 (25.3)
Quartile 4 658 604 (31.7) 380 273 (38.8) 246 984 (42.3) 216 514 (37.5) 1 502 375 (35.6)
Missing 5768 (0.3) 2549 (0.3) 1849 (0.3) 1757 (0.3) 11 923 (0.3)
Educational levelc
Quartile 1 357 873 (17.2) 193 626 (19.8) 86 261 (14.8) 74 793 (13.0) 712 553 (16.9)
Quartile 2 546 606 (26.3) 242 737 (24.8) 130 183 (22.3) 138 133 (23.9) 1 057 659 (25.1)
Quartile 3 673 007 (32.4) 278 269 (28.4) 176 353 (30.2) 196 961 (34.1) 1 324 590 (31.4)
Quartile 4 495 960 (23.9) 262 555 (26.8) 189 629 (32.5) 165 874 (28.7) 1 114 018 (26.4)
Missing 4605 (0.2) 2131 (0.2) 1568 (0.3) 1453 (0.3) 9757 (0.2)
Insurance
Uninsured 43 181 (2.1) 37 407 (3.8) 10 410 (1.8) 10 615 (1.8) 101 613 (2.4)
Private 846 780 (40.7) 425 105 (43.4) 273 302 (46.8) 248 678 (43.1) 1 793 865 (42.5)
Medicaid 88 692 (4.3) 66 032 (6.7) 27 641 (4.7) 27 025 (4.7) 209 390 (5.0)
Medicare 1 050 978 (50.6) 424 020 (43.3) 235 265 (40.3) 279 725 (48.5) 1 989 988 (47.2)
Other government 25 139 (1.2) 10 919 (1.1) 9060 (1.6) 6378 (1.1) 51 496 (1.2)
Missing 23 281 (1.1) 15 835 (1.6) 28 316 (4.8) 4793 (0.8) 72 225 (1.7)
Charlson-Deyo comorbidity score
0 1 502 788 (72.3) 733 013 (74.8) 453 972 (77.7) 418 045 (72.4) 3 107 818 (73.7)
1 417 813 (20.1) 179 081 (18.3) 96 595 (16.5) 114 434 (19.8) 807 923 (19.2)
2 111 789 (5.4) 46 015 (4.7) 23 062 (3.9) 31 180 (5.4) 212 046 (5.0)
≥3 45 661 (2.2) 21 209 (2.2) 10 365 (1.8) 13 555 (2.3) 90 790 (2.2)
Prior cancer
No 1 723 818 (83.0) 816 725 (83.4) 474 573 (81.3) 476 094 (82.5) 3 491 210 (82.8)
Yes 354 135 (17.0) 162 542 (16.6) 109 409 (18.7) 101 038 (17.5) 727 124 (17.2)
Missing 98 (0.0) 51 (0.0) 12 (0.0) 82 (0.0) 243 (0.0)
Distance to hospital, median (IQR), mi 8.9 (4.0-19.7) 10.0 (4.6-23.4) 23.7 (9.2-62.9) 8.6 (4.2-17.1) 10.1 (4.5-23.6)
Transfer of care
No 1 511 776 (72.7) 627 456 (64.1) 243 245 (41.7) 393 567 (68.2) 2 776 044 (65.8)
Yes 566 275 (27.3) 351 862 (35.9) 340 749 (58.3) 183 647 (31.8) 1 442 533 (34.2)
Geographic location
Metropolitan 1 617 679 (77.8) 856 553 (87.5) 483 607 (82.8) 505 543 (87.6) 3 463 382 (82.1)
Nonmetropolitan 410 826 (19.8) 102 638 (10.5) 86 922 (14.9) 48 841 (8.5) 649 227 (15.4)
Missing 49 546 (2.4) 20 127 (2.1) 13 465 (2.3) 22 830 (4.0) 105 968 (2.5)
Cancer type
Breast 654 927 (31.5) 252 221 (25.8) 119 379 (20.4) 169 845 (29.4) 1 196 372 (28.4)
Lung 319 384 (15.4) 148 390 (15.2) 89 665 (15.4) 84 292 (14.6) 641 731 (15.2)
Prostate 344 016 (16.6) 181 829 (18.6) 127 272 (21.8) 101 910 (17.7) 755 027 (17.9)
Colon 270 978 (13.0) 92 056 (9.4) 32 755 (5.6) 68 508 (11.9) 464 297 (11.0)
Rectal 48 204 (2.3) 21 506 (2.2) 13 025 (2.2) 11 691 (2.0) 94 426 (2.2)
Melanoma 64 361 (3.1) 38 973 (4.0) 40 446 (6.9) 20 477 (3.5) 164 257 (3.9)
Bladder 22 944 (1.1) 12 578 (1.3) 10 631 (1.8) 5939 (1.0) 52 092 (1.2)
NHLd 85 043 (4.1) 44 027 (4.5) 36 221 (6.2) 20 871 (3.6) 186 162 (4.4)
Kidney 115 368 (5.6) 67 353 (6.9) 45 456 (7.8) 36 390 (6.3) 264 567 (6.3)
Uterine 111 300 (5.4) 87 429 (8.9) 38 329 (6.6) 43 487 (7.5) 280 545 (6.7)
Pancreatic 41 526 (2.0) 32 956 (3.4) 30 815 (5.3) 13 804 (2.4) 119 101 (2.8)
Cancer stage
I 847 390 (40.8) 401 617 (41.0) 218 190 (37.4) 246 066 (42.6) 1 713 263 (40.6)
II 656 528 (31.6) 301 344 (30.8) 179 625 (30.8) 182 014 (31.5) 1 319 511 (31.3)
III 337 202 (16.2) 158 073 (16.1) 98 817 (16.9) 90 929 (15.8) 685 021 (16.2)
IV 236 931 (11.4) 118 284 (12.1) 87 362 (15.0) 58 205 (10.1) 500 782 (11.9)
First treatment
Surgery 1 497 871 (72.1) 692 898 (70.8) 387 950 (66.4) 437 582 (75.8) 3 016 301 (71.5)
Radiation 230 853 (11.1) 103 854 (10.6) 50 130 (8.6) 62 649 (10.9) 447 486 (10.6)
Systemic 349 327 (16.8) 182 566 (18.6) 145 914 (25.0) 76 983 (13.3) 754 790 (17.9)

Abbreviations: IQR, interquartile range; NCI, National Cancer Institute; NHL, non-Hodgkin lymphoma.

a

Data are presented as number (percentage) of patients unless otherwise specified.

b

Quartile at the zip code level. From 2007 to 2012, quartile 1 was less than $38 000; quartile 2, $38 000 to $47 999; quartile 3, $48 000 to $62 999; and quartile 4, greater than $63 000. From 2013 to 2016, quartile 1 was less than $40 227; quartile 2, $40 227 to $50 353; quartile 3, $50 354 to $63 332; and quartile 4, greater than $63 333.

c

Quartiles at the zip code level for the percentage of adults who did not graduate high school. From 2007 to 2012, quartile 1 was 21% or more; quartile 2, 13% to 20.9%; quartile 3, 7% to 12.9%; and quartile 4, less than 7%. From 2013 to 2016, quartile 1 was 17.6% or more; quartile 2, 10.9% to 17.5%; quartile 3, 6.3% to 10.8%; and quartile 4, less than 6.3%.

d

Includes chronic lymphocytic leukemia and small lymphocytic lymphoma.